Highlights Renalytix Plc OTC Markets

Equities

Market Closed - OTC Markets Other stock markets 14:03:59 2024-06-13 EDT			5-day change	1st Jan Change
0.16 ^USD	-20.00%		0.00%	+3.83%

06-28	ADRs Advance; Connect Biopharma Holdings Climbs 19%	DJ
06-28	EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows	AN

ADRs Advance; Connect Biopharma Holdings Climbs 19%	06-28	DJ
EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows	06-28	AN
Renalytix Requests Hearing With Nasdaq to Maintain Listing	06-28	MT
Renalytix to Appeal Nasdaq Delisting Over Non-compliance	06-25	MT
Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test	06-14	MT
Shares in Renalytix jump as Medicare issues LCD for kidneyintelX.dkd	06-14	AN
Vertu Motors ups dividend as hails record revenue	05-15	AN
Earnings Flash (RNLX) RENALYTIX Reports Q3 Revenue $535,000	05-15	MT
Renalytix Plc Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-15	CI
Renalytix Issues New Shares for Convertible Bonds Repayment	04-10	MT
FTSE 100 Index Closes Up 0.4% Lifted by Miners	04-08	DJ
Renalytix announces financing of up to USD4 million	04-08	AN
Renalytix to Raise Up to $4 Million via Share Offering	04-08	MT
Horizonte subsidiary hit with debt injunction	03-14	AN
Renalytix plc's KidneyIntelX Included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease	03-14	CI
ADRs End Higher, ATRenew Inc. Climbs 26.9%	03-12	DJ
The FTSE 100 Closes Down 0.5% as UK Budget Looms Large on the Horizon	03-04	DJ
Renalytix Kicks Off Formal Sale Process Following Approach from Unnamed Diagnostics Company	03-04	MT
Renalytix shares up as company commences formal sale process	03-04	AN
Renalytix Expands US Coverage for Kidney Disease Test	02-29	MT

No results for this search